Quest Diagnostics (DGX) Accounts Payables (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Accounts Payables data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Accounts Payables rose 18.39% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 18.39% YoY) and the FY2025 annual result came in at $1.6 billion, up 14.78% from the prior year.
• Accounts Payables fell to $1.5 billion in Q1 2026 per DGX's latest filing, from $1.6 billion in the prior quarter.
• The five-year high for Accounts Payables was $1.6 billion in Q4 2025, with the low at $1.2 billion in Q3 2023.
• Average Accounts Payables over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
• Year-over-year, Accounts Payables dropped 22.41% in 2023 and increased 18.39% in 2026.
• Quest Diagnostics' Accounts Payables stood at $1.4 billion in 2022, then dropped by 2.65% to $1.4 billion in 2023, then increased by 2.58% to $1.4 billion in 2024, then rose by 14.78% to $1.6 billion in 2025, then declined by 6.25% to $1.5 billion in 2026.
• Business Quant data shows DGX's Accounts Payables at $1.5 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 billion in Q3 2025.